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Background: This study aimed to identify the determinant factors for clinical outcomes and survival rates of
patients with cardiac arrest (CA) concurrent with acute myocardial infarction (AMI) who underwent extracorporeal
cardiopulmonary resuscitation (ECPR) using extracorporeal membrane oxygenation (ECMO).
Methods: We retrospectively evaluated 37 patients admitted to our emergency department between January 2006
and August 2012 for AMI-induced CA treated with ECPR during ongoing continuous chest compressions.
Results: Mean patient age was 61.4 ± 11.3 years, and 27 patients (73%) were men. Mean CPR time was 50.8 ± 35.4 min.
Door-to-ECMO and door-to-balloon times were 84.4 ± 55.3 and 98.4 ± 56.8 min, respectively. Mean ECMO time was
106.4 ± 84.7 h; nine (24%) patients died within 24 h after ECMO initiation. Twelve (32%) patients were weaned off
ECMO, seven (19%) of whom survived >30 days after ECMO removal; all except one had Cerebral Performance
Category Grade 1. Of the patients who survived, 5 of them were able to be discharged. In multivariate analysis,
statistical significance was only observed in door-to-ECMO time ≤60 min (OR, 6.0; 95% CI, 1,177–852.025; p = 0.033).
Conclusion: We conclude that ECMO insertion within 60 min of the arrival of patients with AMI and CA at the ED
appears to be a good option for maintaining myocardial and systemic perfusion, thereby increasing the survival rate of
these patients.
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Although prehospital management and early revasculari-
zation therapy have considerably contributed to enhance
the survival rate of patients with acute myocardial in-
farction (AMI) concurrent with cardiogenic shock or
cardiac arrest (CA), these are the most fatal complica-
tions associated with the high mortality rate of AMI
[1-4]. Some reports have recently presented cases in* Correspondence: cskhs99@hallym.or.kr
2Department of Thoracic and Cardiovascular Surgery, Hallym University Medical
Center, Hallym University College of Medicine, 77 Sakju-ro, Chuncheon 200-704,
Republic of Korea
Full list of author information is available at the end of the article
© 2015 Han et al.; licensee BioMed Central. Th
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.which extracorporeal membrane oxygenation (ECMO)
was successfully administered to patients with AMI con-
current with cardiogenic shock, thus enhancing their
survival rate [5-9]. Moreover, the use of ECMO is in-
creasing because, in combination with cardiopulmonary
resuscitation (CPR), ECMO has superior efficacy com-
pared to that of conventional CPR in the treatment of
in-hospital CA cases due to various causes [10].
Since not much is known about the practice of extra-
corporeal cardiopulmonary resuscitation (ECPR) using
ECMO in patients with AMI-induced CA, we conductedis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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combined with ECPR as well as the factors influencing
survival in patients with AMI and CA.Methods
Patient enrolment criteria and pre-ECMO management
ECMO was performed for 124 patients with acute heart
failure or acute respiratory failure, for which conven-
tional treatment was ineffective, between January 2006
and August 2012 in the 400-bed Hallym University
Chuncheon Sacred Heart Hospital affiliated with Hallym
University located in a small town with a population of
300,000. Among the 71 patients who received ECMO on
the day of admission to the emergency department (ED),
we conducted a retrospective study on 37 patients who
received veno-arterial ECMO upon the recurrence of
CA within 20 min after the return of spontaneous circu-
lation (ROSC) or due to no signs of ROSC after >10 min
of CPR following AMI-induced CA (Figure 1). All pa-
tients underwent ECMO during ongoing continuousECMO, N=1







Figure 1 Flow diagram of the study population and outcome. ECMO,
infarction; CA, cardiac arrest; ED, emergency department; OHCA, out-of-hos
cardiopulmonary resuscitation.chest compressions. CPR time was calculated by sub-
tracting ROSC time from the total chest compression
time. Patients with unwitnessed cardiac arrest, ongoing
intracranial hemorrhage, or terminal cancer were ex-
cluded. This study was approved by the institutional re-
view board of Hallym University Chuncheon Sacred
Heart Hospital (IRB No. 2012-91).ECMO equipment
Three types of centrifugal pumps were used to deliver
the ECMO: Capiox Emergency Bypass System® (Terumo,
Inc., Tokyo, Japan) and Bio-pump® (Medtronic Inc.,
Minneapolis, MN, USA) were used from 2006 to May
2010; from June 2010 onward, a Centrifugal Rotaflow
pump® (Maquet Inc., Hirrlingen, Germany) was used in
most patients. Depending on patient size, we used 17–21
Fr arterial cannulae (DLP®, Bio-Medicus, Medtronic Inc.;
or RMI®, Edwards Lifesciences LLC, Irvine, CA, USA) and
17–28 Fr venous cannulae (DLP®, Bio-Medicus, Medtronic
Inc.; or RMI®, Edwards Lifesciences LLC).24
 on ED N=39










AMI without CA, N=5
extracorporeal membrane oxygenation; AMI, acute myocardial
pital CA; Cath Lab, catheterization laboratory; ECPR, extracorporeal
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Because the cardiac catheterization laboratory is located
next to the ED, all candidates for ECMO were relocated
to the catheterization laboratory. Here, ECMO cannula-
tion was performed for all patients via the femoral artery
and femoral vein using the Seldinger method following
an intravenous injection of 50–80 U/kg heparin. Heparin
was administered at 300–1400 U/h under the mainten-
ance of activated clotting time (ACT) at 140–180 s from
January 2006 to September 2008; from October 2008 on-
ward, nafamostat mesilate (SK Chemicals Life Science
Biz., Seoul, Korea Licensed by Torii Pharmaceutical Co.
Ltd, Tokyo, Japan) was administered at 0.4–1.5 mg · kg−1 ·
h−1 under the maintenance of partial thromboplastin time
at 60–80 s [11].
All patients underwent percutaneous coronary inter-
vention (PCI) after ECMO. The ECMO flow was main-
tained at 3.0–4.0 L/min, while the mean blood pressure
was sustained at >60 mmHg. If necessary, norepineph-
rine or dopamine was also administered. On the day of
PCI, clopidogrel and aspirin were administered at doses
of 300 mg and 250 mg, respectively; from the second
day onward, the doses were 75 mg and 100–200 mg, re-
spectively. Care was taken to maintain the hematocrit
level and platelet count at 35% and 80,000/μL, respect-
ively, and transfusion was performed when these values
decreased. ECMO was removed when the ejection frac-
tion exceeded 30% at the ECMO flow of 1 L/min on
echocardiography. Successful ECMO weaning and sur-
vival were defined as cases of survival >24 h and >30 d,
respectively, after the removal of ECMO.
Statistical analysis
Statistical analyses were performed using IBM SPSS
Statistics (ver. 21; IBM Co., NY, USA); continuous and
categorical variables were analysed by the Mann Whit-
ney U-test and the Pearson chi square test or Fisher’s
exact test, respectively. The univariate and multivariate
stepwise logistic regression analysis model was used to
identify independent survival-related factors. Values of
p < 0.05 were considered statistically significant. Survival
outcomes of the patients who survived CA were analysed
using the Kaplan-Meier survival method.
Results
Patient profiles
To evaluate the efficacy of ECPR for AMI with refrac-
tory cardiac arrest, the patients were devided into 2
groups based on whether survived >30 days after the re-
moval of ECMO or not. Among the baseline clinical
characteristics of patients, no statistically significant in-
tergroup differences were observed in gender; past med-
ical history; smoking history; pre-ECMO laboratory
findings of creatinine, total bilirubin, creatine kinase-MB, myoglobin, troponin-I, lactate; Sequential Organ
Failure Assessment score; and the transfusion volume of
cryoprecipitate and platelet concentrates. In contrast,
statistically significant intergroup differences were ob-
served in patient age, pre-ECMO laboratory findings on
blood urea nitrogen, duration of ECMO, and Simplified
Acute Physiology Score II (SAPS II) score. ECMO weaning
was possible in 12 (32%) of 34 patients, seven (19%) who
survived >30 days and five (14%) who were discharged. Of
the seven surviving cases (86%), six were classified as
Cerebral Performance Category (CPC) Grade 1 and
one patient (14%) as CPC Grade 4 (Table 1).
CPR-related and coronary angiographic characteristics
Fourteen (38%) patients underwent out-of-hospital CPR.
There was a statistically significant difference between
the two groups in door-to-ECMO time and use of intra-
aortic balloon pump (IABP), although no statistically sig-
nificant intergroup differences were found in the status
on arrival, transit time from scene of CA to the hospital
for out-of-hospital CA, CPR time, ROSC > 20 min dur-
ing CPR, door-to-balloon time, post-ECMO return of
spontaneous beat (ROSB), and CPR-related complica-
tions (Table 2).
Among the coronary angiography findings, no statisti-
cally significant intergroup differences were seen in the
number of lesions, location of infarction-related arteries,
or PCI type (Table 3).
Complications and cause of death
Of the patients who survived, five (71%) developed
pneumonia, three (43%) developed bed sores, and two
patients each (29%) developed cannula-related complica-
tions and acute renal failure. The major causes of death
were myocardial dysfunction (n = 10; 33%) and CPR-
related complications such as hypoxic brain damage,
chest wall compartment syndrome, hemothorax, and
pulmonary hemorrhage (n = 12; 40%). The other causes
of death were sepsis in four patients, systemic inflamma-
tory reaction syndrome in two, intracranial hemorrhage
in two, and multi-organ failure in one patient.
Univariate and multivariate analysis of independent
factors of survival
The univariate analysis performed to determine the in-
dependent patient survival-related factors demonstrated
statistical significance for door-to-ECMO time ≤60 min
(odds ratio [OR], 19.714; 95% confidence interval [CI],
2.017–192.70; p = 0.010), pre-ECMO BUN (OR, 0.834;
95% CI, 0.701–0.992; p = 0.040), and SAPS II score ≤85
(OR, 19.714; 95% CI, 2.017–192.70; p = 0.010). However,
in multivariate analysis, statistical significance was ob-
served only for door-to-ECMO time ≤60 min (OR, 6.0;
95% CI, 1,177–852.025; p = 0.033) (Table 4).
Table 1 Comparison of baseline clinical characteristics
between non-survivors and survivors
Non-survivors Survivors p
n = 30 n = 7
Age, years, mean (SD) 63.2 (10.9) 53.7 (10.2) 0.049
Gender, male 20 (67%) 7 (100%) 0.155*
BMI, mean (SD) 24.2 (2.8) 22.5 (1.3) 0.151
Past medical history
Hypertension 18 (60%) 2 (29%) 0.212*
Diabetes 19 (63%) 2 (29%) 0.202*
Cerebral vascular accident 3 (10%) 1 (14%) 1.000*
Dyslipidemia 3 (10%) 2 (29%) 0.233*
Previous PCI 1 (3%) - 1.000*
Smoking 14 (47%) 4 (57%) 0.693*
Pre-ECMO laboratory findings,
mean (SD)
BUN 21.69 (7.47) 14.74 (4.65) 0.019
Cr 1.55 (0.77) 1.16 (0.05) 0.065
TB 0.73 (0.35) 0.81 (0.30) 0.474






Troponin-I 22.02 (54.70) 0.28 (0.30) 0.751
pH 6.95 (0.15) 7.00 (0.15) 0.345
Lactate 10.15 (4.36) 7.73 (2.79) 0.448
BNP 734.67 (1177.84) 17.40 (15.37) 0.008
ECMO duration, h, mean (SD) 94.63 (86.20) 156.71 (58.99) 0.029
SOFA score, mean (SD) 15.10 (1.54) 13.86 (1.07) 0.051
SAPS II score, mean (SD) 92.43 (7.95) 80.14 (6.36) 0.001
Daily blood transfusion during
ECMO, units/day, mean (SD)
Packed red blood cell 6.36 (6.04) 2.26 (3.52) 0.002
Fresh frozen plasma 5.00 (4.96) 1.72 (3.04) 0.006
Cryoprecipitate 1.44 (2.61) 1.43 (2.43) 0.635
Platelet concentrate 2.97 (2.83) 2.99 (2.77) 0.747
Outcomes
Weaning success 5 (17%) 7 (100%)
Discharged - 5 (71%)
CPC grade
1 - 6 (86%)
4 - 1 (14%)
BMI, body mass index; PCI, percutaneous coronary intervention; VT/VF,
ventricular tachycardia/ventricular fibrillation; PEA, pulseless electrical activity;
ECMO, extracorporeal membrane oxygenation; BUN, blood urea nitrogen; Cr,
creatinine; TB, tuberculosis; CK-MB, creatine kinase-MB; BNP, brain natriuretic
peptide; CRRT, continuous renal replacement therapy; SOFA, Sequential Organ
Failure Assessment; SAPS II, Simplified Acute Physiology Score II; CPC, Cerebral
Performance Category.
*Fisher’s Exact test.
Table 2 Comparison of CPR-related characteristics between
non-survivors and survivors
Non-survivors Survivors p
n = 30 n = 7
Status on arrival 0.395**
Unstable vital sign 7 (23%) -
Cardiogenic shock 11 (37%) 2 (29%)
VT/Vf 10 (33%) 4 (57%)
PEA 1 (3%) 1 (14%)
Asystole 1 (3%) -
CPR location 0.080*
Out of hospital 9 (30%) 5 (71%)
In-ED/Cath lab 21 (70%) 2 (29%)
Transit time from Victims
scene to hospital of OHCA
18.0 ± 17.9 22 ± 18.7 0.643
CPR time, min, mean (SD) 52.23 (37.18) 44.71 0.635
ROSC >20 min during CPR 9(30%) 1(14%) 0.647*
Door to balloon time, min,
mean (SD)
107.44 (60.61) 66.14 (21.06) 0.054
Door to ECMO time, min,
mean (SD)
94.10 (56.96) 42.86 (14.53) 0.001
ROSB After ECMO 28 (93%) 7 (100%) 1.000*
IABP 0.032**
Pre-/with ECMO 10(33%) -
After ECMO removal - 1(14%)
CPR-related complications 0.181**
Hemothorax 3 (10%) -
Chest wall compartment 4 (13%) -
Hypoxic brain damage 9 (30%) 2 (29%)
Pulmonary haemorrhage 5 (17%) -
CPR, cardiopulmonary resuscitation; ED, emergency department; Cath lab,
catheter laboratory; ECMO, extracorporeal membrane oxygenation; ROSB,
return of spontaneous beat. ROSC time is not excluded.
*Fisher’s Exact test; **Pearson chi-square test.
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50th and 94th days, and all five patients who were dis-
charged (CPC Grade 1) survived a median of 45 (range,
11–84) months without the occurrence of serious com-
plications on post-ECMO follow-up (Figure 2).
Discussion
The survival rates of the patients with out-of-hospital
AMI-induced CA who received emergency PCI after a
post-CPR ROSC were 38–86% according to inclusion
criteria. This is clear evidence of the importance of
promptly opening a blocked coronary artery after ROSC
in patients with AMI-induced CA [1-3,12]. However, in
the hypoxic state caused by the reduced perfusion of
other organs during CA, it is difficult to restore the func-
tions of other damaged organs using cardiac reperfusion
alone as long as cardiac function is not sufficiently
Table 3 Comparison of angiographic characteristics
between non-survivors and survivors
Non-survivors Survivors p
n = 30 n = 7
Coronary angiographic findings 0.157**
Spasm 3 (10%) -
Left main 1 (3%) 2 (29%)
One vessel 6 (20%) -
Two vessels 11 (37%) 3 (43%)
Three vessels 9 (30%) 2 (29%)
Infarction-related artery 0.285**
Left main 8 (27%) 4 (57%)
Left anterior descending 10 (33%) 1 (14%)




Stent 19 (63%) 7 (100%)
Balloon 5 (17%) -
Failed 2 (7%) -
No procedure 4 (13%) -
Three patients showed spontaneous reperfusion in the coronary artery spam
during the no-procedure period, but the procedure could not be pursued in
one patient who had received bronchial artery embolization because of a
continuing massive pulmonary hemorrhage.
**Pearson chi-square test.
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the use of large amounts of inotropic agents or an IABP,
patients with serious conditions are likely to develop
metabolic acidosis due to decreased systemic perfusion,
which eventually results in a high mortality rate.
The use of ECMO is highly effective in treating such
patients [5,8,13,14]. If ECMO is performed in combin-
ation with IABP, IABP-induced pulsatility reduces cor-
onary vascular resistance, thereby increasing coronary
blood flow and graft flow, and contributing to the re-
covery of cardiac function [15,16]. However, in our
study, eight patients who received pre-ECMO IABP
died, presumably because the lapse of time for IABP
insertion and procedure as well as response observa-
tion had an adverse effect on the deteriorated systemic
perfusion caused by the seriously reduced cardiac
function, thus prolonging the state of reduced tissue per-
fusion and not contributing to the patients’ recovery. InTable 4 Univariate analysis and multiple logistic regression a
Variables Univariate analysis
OR 95% CI
Door-to-ECMO time ≤60 min 19.714 2.017–192.702
Pre-ECMO BUN 0.834 0.701–0.992
SAPS II score ≤85 19.714 2.017–192.702
ECMO, extracorporeal membrane oxygenation; BUN, blood urea nitrogen; SAPS II, Sout-of-hospital CA cases induced by AMI, the procedure
most helpful for the patients’ recovery appears to be the
prompt insertion of ECMO on arrival at the ED to restore
tissue perfusion, followed by opening the blocked coron-
ary artery and reducing the amount of inotropic agents
administered while ECMO is maintained. Therefore, if a
patient with AMI and unstable vital signs or cardiogenic
shock arrives at the ED, the prompt use of ECMO should
be considered meanwhile the necessary tests, clinical ob-
servation, and diagnostic procedures are conducted be-
cause of possible CA. This prompt action will avoid time
loss during intra-CPR ECMO insertion.
Some studies have found that the shorter the CPR dur-
ation during ECPR in CA cases, the higher is the sur-
vival rate and the better are the neurologic outcomes
[17]. Furthermore, ECPR is more effective than conven-
tional CPR [10], and patients with in-hospital CA have a
better chance of survival than patients with out-of-
hospital CA [18]. Our study did not find a statistically
significant difference in the patients’ CPR time because
of the ECMO implantation protocol. However, the door-
to-ECMO time was less than 90 min in all survival cases.
The survival of AMI-induced CA was influenced by the
duration of cardiogenic shock, including CPR time until
ECMO implantation from the moment of arrival at the
ED, which is the reason why the predictor of survival
door-to-ECMO time ≤ 60 min. The patients who devel-
oped CA in the ED or catheter laboratory had a rela-
tively high ECMO weaning rate of 32% (7/22); however,
their survival rate was as low as 9% (2/22). In the case of
five patients who died after ECMO weaning, their car-
diac function had been restored. However, the delayed
recovery of cardiac function because of pulmonary
edema secondary to CPR and cardiogenic shock at the
time of admission in combination with concurrent pneu-
monia (which prolonged the ECMO maintenance time
for lung support) ultimately resulted in multiple-organ
dysfunction caused by ECMO-related systemic inflam-
matory response syndrome with increased plasma con-
centrations of inflammatory cytokines [19]. To reduce
the duration of ECMO, which is prolonged by secondary
acute lung injury, it is necessary to intensively treat the
CPR-induced pulmonary edema or hemorrhage. If pul-
monary edema occurs because of insufficient draining of
the venous cannula, care should be taken to ensure thatnalysis of predictors for survival
Multivariate analysis
p OR 95% CI p
0.010 6.000 1.177–852.025 0.033
0.040 0.756 0.563–1.015 0.063
0.010 32.802 0.988–1088.519 0.051
implified Acute Physiology Score II; OR, odds ratio; CI, confidence interval.
Figure 2 Kaplan-Meier survival curve. All five patients considered fit for discharge survived.
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currence of left atrial (LA) pressure-induced pulmonary
edema parallel to the recovery of left ventricular (LV)
function. This can be achieved by LA decompression
with LA or LV venting through cannula insertion or sep-
tostomy [20-22].
Eight patients in the current study died within 24 h of
CPR-induced hemothorax, pulmonary hemorrhage due
to bronchial artery rupture, or chest compartment syn-
drome. Of the CPR-related complications, the conditions
of the patients who developed hemothorax were very
serious with severe bleeding, so we did not attempt any
surgical treatment. However, considering one recent re-
port [23], in which good results were obtained from sur-
gical treatment, it seems recommendable to address
hemothorax with a more active surgical approach. Fur-
thermore, preventing transfusion-related acute lung injur-
ies can contribute to enhancing patients’ survival rates,
when used during intra-CPR catheterization to avoid
blood loss by diminishing cannula site bleeding [11,24].
When considering the use of ECMO in patients with
AMI and CA, the reduction the CPR duration, and thus
the reduction of the aforementioned CPR-related compli-
cations, is important to improve the survival rate. Further,
the combination of ECMO, and myocardial reperfusion
via PCI can ensure good tissue perfusion at an earlier
stage.The major limitations of this study are that it was
retrospective in nature and included a small number of
patients, and that a comparative study with AMI pa-
tients with cardiac arrest who went through conven-
tional treatment wasn’t done. Therefore, a prospective
study that includes a group of patients with AMI and
CA is required to investigate a target patient group for
the application of ECPR.
Conclusions
We conclude that ECMO insertion within 60 min of the
arrival of patients with AMI and CA at the ED appears
to be a good option for maintaining myocardial and sys-
temic perfusion, thereby increasing the survival rate of
these patients.
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